SCHEMBL22484858

SCHEMBL22484858

O=Cc1cc(C(=O)Nc2ccc(N3[C@H]4CC[C@H]3CC4)cc2)cc(F)c1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 1/20 0.43
▸ TOP2A P11388 1/20 0.43
▸ TOP2B Q02880 1/20 0.43
▸ SNCA P37840 4/20 0.42
▸ ERN1 O75460 6/20 0.40
▸ BRD4 O60885 3/20 0.40
▸ KCNQ3 O43525 1/20 0.38
▸ KCNQ2 O43526 1/20 0.38
▸ NPC1 O15118 3/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ TP53 P04637 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ HRH3 Q9Y5N1 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22466028 1.00 TOP1 (0.43) TOP1TOP2ATOP2BSNCAERN1
SCHEMBL22466002 1.00 TOP1 (0.43) TOP1TOP2ATOP2BSNCAERN1
SCHEMBL22466111 0.98 TOP1 (0.41) TOP1TOP2ATOP2BSNCAERN1
SCHEMBL22466015 0.98 TOP1 (0.41) TOP1TOP2ATOP2BSNCAERN1
SCHEMBL22466083 0.86 HRH3 (0.44) NPC1RAB9ASMN1; SMN2TP53MAPT
SCHEMBL29549366 0.84 NPC1 (0.42) TOP1TOP2ATOP2BSNCAERN1
SCHEMBL22465937 0.84 NPC1 (0.42) TOP1TOP2ATOP2BSNCAERN1
SCHEMBL22466035 0.83 RAB9A (0.57) KCNQ3KCNQ2NPC1RAB9ASMN1; SMN2
SCHEMBL29377773 0.83 RAB9A (0.57) KCNQ3KCNQ2NPC1RAB9ASMN1; SMN2
SCHEMBL29375281 0.82 RAB9A (0.47) NPC1RAB9ASMN1; SMN2TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020198368-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING NEUROPORE THERAPIES, INC. (US) 2020-10-01 — — WO disclosed
Send feedback